Under the dazzling lights of Vision Expo East, the team at Eyes On Eyecare approached optometrists with a tantalizing offer: $1 or a Mystery Gift!
The mystery gifts were theirs for the taking under one condition: answer a question about SMILE refractive surgery.
While some optometrists may still be unfamiliar with SMILE, it is rapidly gaining popularity because of its predictability, excellent initial outcomes, and rapid recovery time.
How much did your colleagues know about SMILE when we put them on the spot?
Watch your optometry friends' full reactions on TikTok!
Find out who the SMILE pro is and who needs to up their game.
Overview of SMILE refractive surgery
Small incision lenticule extraction—better known as SMILE in today’s eyecare circles—represents one of the most recently envisioned, unique, and minimally invasive forms of keratorefractive surgery.
In this bladeless procedure, the femtosecond laser is employed to create a small “pocket” in the anterior corneal stroma by making two disc-shaped ablative cuts, effectively forming a lenticule (i.e., a thin, lens-shaped layer) of corneal tissue inside the pocket (Figure 1). The laser also creates a small tunnel incision at the edge of the lenticule, which allows for surgical extraction of the disc in a minimally-invasive fashion.1
The end result is similar to laser-assisted in situ keratomileusis (LASIK), but without any flap-related complications and potentially with a much faster recovery time.2
Figure 1 is a graphical representation of SMILE from left to right: The femtosecond laser dissects the central cornea in two parallel planes that overlap at the periphery, creating a lenticule of corneal stroma between the incisions. This is removed by a small peripheral tunnel to the cap interface from the corneal surface, also created by the laser, and when the lenticule is removed, the cornea assumes a new shape, which corrects the refractive error.
Figure 1: Courtesy of ZEISS.
Developments in SMILE refractive surgery
Interestingly, the concept behind SMILE was first described by Ito and associates nearly 30 years ago, using a picosecond laser to fashion intrastromal lenticules in human donor eyes.3
With the introduction of the VisuMax femtosecond laser (Carl Zeiss Meditec), however, this procedure moved from theory to reality. The first small clinical trial demonstrating the potential of femtosecond lenticule extraction in myopic patients was published in 2008.4 Subsequently, several larger, prospective trials to evaluate the safety and efficacy of SMILE were conducted.5,6,7
VisuMax 800 for SMILE refractive surgery
The VisuMax laser was initially approved by the US Food and Drug Administration (FDA) in 2016 for the treatment of spherical myopia.8 In January of 2024, the FDA granted approval for the VisuMax 800 with SMILE pro software, intended to surgically treat myopia with or without astigmatism.9
The VisuMax 800 is purported to have a four-fold faster laser repetition rate compared to the first-generation VisuMax (2MHz vs. 500kHz)—making it the most efficient design to date for performing SMILE.
In head-to-head clinical comparisons, SMILE has generally been found to have early post-operative outcomes similar to LASIK and superior to photorefractive keratectomy (PRK) in terms of visual outcome and post-surgical discomfort.10 Some studies suggest that SMILE offers a shorter recovery of post-operative dry eye and glare as compared to LASIK.10,11
Another study demonstrated marked improvement in corrected distance acuity along with excellent predictability for both SMILE and wavefront-guided LASIK; however, the latter resulted in faster visual recovery, better low-contrast visual acuity, and greater gains in uncorrected visual acuity.12
The FDA has approved SMILE for the treatment of up to 10.00 diopters of myopia and 0.75 to 3.00 diopters of astigmatism. At this time, however, the procedure is not approved for treating hyperopia.
Some advantages of SMILE may include:
- A small incision, with little-to-no propensity for flap complications.
- Rapid recovery time that is comparable to LASIK and superior to surface ablation.
- SMILE is favorable toward the preservation of corneal nerves, reducing the likelihood of secondary dry eye disease (DED) or neurotrophic keratopathy.
Conclusion
While SMILE has yet to overtake LASIK as the treatment of choice for the majority of patients, it nonetheless has some extremely appealing qualities that make for a highly persuasive argument.
The most obvious reasons to favor SMILE over surface ablation procedures and even LASIK are the preservation of corneal nerves (i.e., less risk of post-operative DED) and the minimization of post-operative discomfort and visual rehabilitation.
With SMILE being performed on over 8 million eyes worldwide, it behooves the ECP to understand the unique advantages of this refractive surgery procedure and identify patients who may be excellent candidates for this increasingly popular technique.